Doximity [DOCS] vs Ge Healthcare [GEHC] Detailed Stock Comparison
Doximity
NYSE
Loading...
Ge Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Doximity wins in 7 metrics, Ge Healthcare wins in 12 metrics, with 0 ties. Ge Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Doximity | Ge Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 52.84 | 15.25 | Ge Healthcare |
| Price-to-Book Ratio | 11.30 | 3.50 | Ge Healthcare |
| Debt-to-Equity Ratio | 1.16 | 107.67 | Doximity |
| PEG Ratio | 51.95 | 15.93 | Ge Healthcare |
| EV/EBITDA | 44.08 | 11.04 | Ge Healthcare |
| Profit Margin (TTM) | 39.88% | 11.22% | Doximity |
| Operating Margin (TTM) | 37.48% | 14.62% | Doximity |
| EBITDA Margin (TTM) | 37.48% | 14.62% | Doximity |
| Return on Equity | 24.25% | 25.80% | Ge Healthcare |
| Return on Assets (TTM) | 13.13% | 5.77% | Doximity |
| Free Cash Flow (TTM) | $266.74M | $1.55B | Ge Healthcare |
| Dividend Yield | N/A | 0.24% | N/A |
| 1-Year Return | 82.18% | -13.44% | Doximity |
| Price-to-Sales Ratio (TTM) | 19.64 | 1.70 | Ge Healthcare |
| Enterprise Value | $10.75B | $40.55B | Ge Healthcare |
| EV/Revenue Ratio | 18.23 | 2.03 | Ge Healthcare |
| Gross Profit Margin (TTM) | 89.18% | 39.65% | Doximity |
| Revenue per Share (TTM) | $3 | $44 | Ge Healthcare |
| Earnings per Share (Diluted) | $1.17 | $4.88 | Ge Healthcare |
| Beta (Stock Volatility) | 1.36 | 1.28 | Ge Healthcare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Doximity vs Ge Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Doximity | 2.50% | -2.18% | 4.96% | 11.43% | -16.42% | 21.60% |
| Ge Healthcare | -0.35% | 1.94% | -1.33% | 0.67% | -20.79% | -6.35% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Doximity | 82.18% | 97.30% | 16.35% | 16.35% | 16.35% | 16.35% |
| Ge Healthcare | -13.44% | 29.36% | 29.36% | 29.36% | 29.36% | 29.36% |
Performance & Financial Health Analysis: Doximity vs Ge Healthcare
| Metric | DOCS | GEHC |
|---|---|---|
| Market Information | ||
| Market Cap | $11.58B | $33.97B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,390,453 | 5,034,167 |
| 90 Day Avg. Volume | 1,815,488 | 3,925,566 |
| Last Close | $65.13 | $73.40 |
| 52 Week Range | $34.34 - $85.21 | $57.65 - $94.80 |
| % from 52W High | -23.57% | -22.57% |
| All-Time High | $107.79 (Sep 06, 2021) | $94.80 (Feb 10, 2025) |
| % from All-Time High | -39.58% | -22.57% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.04% |
| Quarterly Earnings Growth | 0.29% | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.40% | 0.11% |
| Operating Margin (TTM) | 0.37% | 0.15% |
| Return on Equity (TTM) | 0.24% | 0.26% |
| Debt to Equity (MRQ) | 1.16 | 107.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.47 | $21.27 |
| Cash per Share (MRQ) | $4.49 | $8.19 |
| Operating Cash Flow (TTM) | $294.12M | $2.00B |
| Levered Free Cash Flow (TTM) | $231.29M | $1.58B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.24% |
| Last 12-Month Dividend | N/A | $0.18 |
Valuation & Enterprise Metrics Analysis: Doximity vs Ge Healthcare
| Metric | DOCS | GEHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 52.84 | 15.25 |
| Forward P/E | 51.95 | 15.93 |
| PEG Ratio | 51.95 | 15.93 |
| Price to Sales (TTM) | 19.64 | 1.70 |
| Price to Book (MRQ) | 11.30 | 3.50 |
| Market Capitalization | ||
| Market Capitalization | $11.58B | $33.97B |
| Enterprise Value | $10.75B | $40.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 18.23 | 2.03 |
| Enterprise to EBITDA | 44.08 | 11.04 |
| Risk & Other Metrics | ||
| Beta | 1.36 | 1.28 |
| Book Value per Share (MRQ) | $5.47 | $21.27 |
Financial Statements Comparison: Doximity vs Ge Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DOCS | GEHC |
|---|---|---|
| Revenue/Sales | $145.91M | $4.78B |
| Cost of Goods Sold | $15.79M | $2.77B |
| Gross Profit | $130.12M | $2.01B |
| Research & Development | $26.80M | $344.00M |
| Operating Income (EBIT) | $54.52M | $628.00M |
| EBITDA | $57.31M | $842.00M |
| Pre-Tax Income | $64.15M | $692.00M |
| Income Tax | $10.83M | $104.00M |
| Net Income (Profit) | $53.32M | $588.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DOCS | GEHC |
|---|---|---|
| Cash & Equivalents | $209.61M | $2.45B |
| Total Current Assets | $1.09B | $9.74B |
| Total Current Liabilities | $156.26M | $9.97B |
| Long-Term Debt | $10.19M | $7.06B |
| Total Shareholders Equity | $1.08B | $9.42B |
| Retained Earnings | $186.89M | $3.81B |
| Property, Plant & Equipment | $8.89M | $369.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DOCS | GEHC |
|---|---|---|
| Operating Cash Flow | $119.90M | $509.00M |
| Capital Expenditures | $0 | $-152.00M |
| Free Cash Flow | $96.98M | $98.00M |
| Debt Repayment | N/A | $-257.00M |
| Common Stock Repurchase | $-26.79M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DOCS | GEHC |
|---|---|---|
| Shares Short | 4.07M | 9.02M |
| Short Ratio | 2.65 | 2.31 |
| Short % of Float | 0.03% | 0.03% |
| Average Daily Volume (10 Day) | 2,390,453 | 5,034,167 |
| Average Daily Volume (90 Day) | 1,815,488 | 3,925,566 |
| Shares Outstanding | 188.88M | 456.96M |
| Float Shares | 133.18M | 455.36M |
| % Held by Insiders | 0.02% | 0.00% |
| % Held by Institutions | 0.96% | 0.81% |
Dividend Analysis & Yield Comparison: Doximity vs Ge Healthcare
| Metric | DOCS | GEHC |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.18 |
| Last 12-Month Dividend Yield | N/A | 0.24% |
| 3-Year Avg Annual Dividend | N/A | $0.11 |
| 3-Year Avg Dividend Yield | N/A | 0.04% |
| 3-Year Total Dividends | N/A | $0.33 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |